BCPC

Balchem Corp

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 50%
Negative

Neutral
GlobeNewsWire
3 days ago
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the Wells Fargo Industrials Conference on June 10, 2026.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Positive
Seeking Alpha
11 days ago
My Top Dividend Growth Picks In Each GICS Sector
I present my top dividend growth picks for each of the 11 GICS sectors, emphasizing discounted valuations and safe, growing dividends. The Sector Winners portfolio outperformed SPY with a 333% five-year return (ex-dividends) and a 0.9% yield; Runners-Up returned 83% with a 1.3% yield. I use a rigorous quality scoring system and sector diversification to minimize dividend cut risks and optimize portfolio resilience.
My Top Dividend Growth Picks In Each GICS Sector
Neutral
Seeking Alpha
29 days ago
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
Balchem Corporation Reports First Quarter 2026 Financial Results
MONTVALE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2026 fiscal first quarter ended March 31, 2026.
Balchem Corporation Reports First Quarter 2026 Financial Results
Positive
Zacks Investment Research
1 month ago
Sherwin-Williams (SHW) Beats Q1 Earnings and Revenue Estimates
Sherwin-Williams (SHW) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.24 per share. This compares to earnings of $2.25 per share a year ago.
Sherwin-Williams (SHW) Beats Q1 Earnings and Revenue Estimates
Negative
Seeking Alpha
1 month ago
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russell 2500 Growth Index's return of -3.52%. RBC's performance was driven by continued strength in aerospace and defense, where demand remains robust and increasingly visible through a growing backlog. Despite a solid quarter, Repligen stock underperformed as investors focused on a more measured outlook and lingering concerns around end-market demand.
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
Neutral
GlobeNewsWire
1 month ago
Balchem Corporation Releases 2025 Sustainability Report
MONTVALE, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today published its 2025 Sustainability Report.
Balchem Corporation Releases 2025 Sustainability Report
Positive
Seeking Alpha
2 months ago
Balchem: An Attractive Valuation Makes This Stock A Buy
Balchem delivered strong Q4 results, with revenue up nearly 10% year-over-year and all segments posting growth. BCPC boasts a 17-year streak of double-digit dividend hikes, supported by a payout ratio consistently below 20%. The stock trades at a roughly 25% discount to its estimated fair value, with robust forward return potential exceeding 14%.
Balchem: An Attractive Valuation Makes This Stock A Buy
Neutral
GlobeNewsWire
2 months ago
Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops
MONTVALE, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Balchem Plant Nutrition, a global leader in chelated mineral plant nutrition and the maker of Metalosate® micronutrients, today announced the launch of its Metalosate® T.E.A.M.
Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops
Positive
The Motley Fool
2 months ago
Balchem Stock Lands New $18 Million Investor as Firm Delivers Record $1 Billion in Sales
Harvey Partners bought 116,000 shares in Balchem Corporation during the fourth quarter. The quarter-end position value increased by $17.79 million due to the new stake in Balchem Corporation.
Balchem Stock Lands New $18 Million Investor as Firm Delivers Record $1 Billion in Sales